Cargando…
APOE/TOMM 40 genetic loci, white matter hyperintensities, and cerebral microbleeds
BACKGROUND: Two markers of cerebral small vessel disease are white matter hyperintensities and cerebral microbleeds, which commonly occur in people with Alzheimer's disease. AIM AND/OR HYPOTHESIS: To test for independent associations between two Alzheimer's disease‐susceptibility gene loci...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950052/ https://www.ncbi.nlm.nih.gov/pubmed/26310205 http://dx.doi.org/10.1111/ijs.12615 |
_version_ | 1782443519537840128 |
---|---|
author | Lyall, Donald M. Muñoz Maniega, Susana Harris, Sarah E. Bastin, Mark E. Murray, Catherine Lutz, Michael W. Saunders, Ann M. Roses, Allen D. Valdés Hernández, Maria del C. Royle, Natalie A. Starr, John M. Porteous, David J. Deary, Ian J. Wardlaw, Joanna M. |
author_facet | Lyall, Donald M. Muñoz Maniega, Susana Harris, Sarah E. Bastin, Mark E. Murray, Catherine Lutz, Michael W. Saunders, Ann M. Roses, Allen D. Valdés Hernández, Maria del C. Royle, Natalie A. Starr, John M. Porteous, David J. Deary, Ian J. Wardlaw, Joanna M. |
author_sort | Lyall, Donald M. |
collection | PubMed |
description | BACKGROUND: Two markers of cerebral small vessel disease are white matter hyperintensities and cerebral microbleeds, which commonly occur in people with Alzheimer's disease. AIM AND/OR HYPOTHESIS: To test for independent associations between two Alzheimer's disease‐susceptibility gene loci – APOE ε and the TOMM 40 ‘523’ poly‐T repeat – and white matter hyperintensities/cerebral microbleed burden in community‐dwelling older adults. METHODS: Participants in the Lothian Birth Cohort 1936 underwent genotyping for APOE ε and TOMM 40 523, and detailed structural brain magnetic resonance imaging at a mean age of 72·70 years (standard deviation = 0·7; range = 71–74). RESULTS: No significant effects of APOE ε or TOMM 40 523 genotypes on white matter hyperintensities or cerebral microbleed burden were found amongst 624 participants. CONCLUSIONS: Lack of association between two Alzheimer's disease susceptibility gene loci and markers of cerebral small vessel disease may reflect the relative health of this population compared with those in other studies in the literature. |
format | Online Article Text |
id | pubmed-4950052 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-49500522016-07-28 APOE/TOMM 40 genetic loci, white matter hyperintensities, and cerebral microbleeds Lyall, Donald M. Muñoz Maniega, Susana Harris, Sarah E. Bastin, Mark E. Murray, Catherine Lutz, Michael W. Saunders, Ann M. Roses, Allen D. Valdés Hernández, Maria del C. Royle, Natalie A. Starr, John M. Porteous, David J. Deary, Ian J. Wardlaw, Joanna M. Int J Stroke Research BACKGROUND: Two markers of cerebral small vessel disease are white matter hyperintensities and cerebral microbleeds, which commonly occur in people with Alzheimer's disease. AIM AND/OR HYPOTHESIS: To test for independent associations between two Alzheimer's disease‐susceptibility gene loci – APOE ε and the TOMM 40 ‘523’ poly‐T repeat – and white matter hyperintensities/cerebral microbleed burden in community‐dwelling older adults. METHODS: Participants in the Lothian Birth Cohort 1936 underwent genotyping for APOE ε and TOMM 40 523, and detailed structural brain magnetic resonance imaging at a mean age of 72·70 years (standard deviation = 0·7; range = 71–74). RESULTS: No significant effects of APOE ε or TOMM 40 523 genotypes on white matter hyperintensities or cerebral microbleed burden were found amongst 624 participants. CONCLUSIONS: Lack of association between two Alzheimer's disease susceptibility gene loci and markers of cerebral small vessel disease may reflect the relative health of this population compared with those in other studies in the literature. John Wiley and Sons Inc. 2015-08-26 2015-12 /pmc/articles/PMC4950052/ /pubmed/26310205 http://dx.doi.org/10.1111/ijs.12615 Text en © 2015 The Authors. International Journal of Stroke published by John Wiley & Sons Ltd on behalf of World Stroke Organization. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Lyall, Donald M. Muñoz Maniega, Susana Harris, Sarah E. Bastin, Mark E. Murray, Catherine Lutz, Michael W. Saunders, Ann M. Roses, Allen D. Valdés Hernández, Maria del C. Royle, Natalie A. Starr, John M. Porteous, David J. Deary, Ian J. Wardlaw, Joanna M. APOE/TOMM 40 genetic loci, white matter hyperintensities, and cerebral microbleeds |
title |
APOE/TOMM
40 genetic loci, white matter hyperintensities, and cerebral microbleeds |
title_full |
APOE/TOMM
40 genetic loci, white matter hyperintensities, and cerebral microbleeds |
title_fullStr |
APOE/TOMM
40 genetic loci, white matter hyperintensities, and cerebral microbleeds |
title_full_unstemmed |
APOE/TOMM
40 genetic loci, white matter hyperintensities, and cerebral microbleeds |
title_short |
APOE/TOMM
40 genetic loci, white matter hyperintensities, and cerebral microbleeds |
title_sort | apoe/tomm
40 genetic loci, white matter hyperintensities, and cerebral microbleeds |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950052/ https://www.ncbi.nlm.nih.gov/pubmed/26310205 http://dx.doi.org/10.1111/ijs.12615 |
work_keys_str_mv | AT lyalldonaldm apoetomm40geneticlociwhitematterhyperintensitiesandcerebralmicrobleeds AT munozmaniegasusana apoetomm40geneticlociwhitematterhyperintensitiesandcerebralmicrobleeds AT harrissarahe apoetomm40geneticlociwhitematterhyperintensitiesandcerebralmicrobleeds AT bastinmarke apoetomm40geneticlociwhitematterhyperintensitiesandcerebralmicrobleeds AT murraycatherine apoetomm40geneticlociwhitematterhyperintensitiesandcerebralmicrobleeds AT lutzmichaelw apoetomm40geneticlociwhitematterhyperintensitiesandcerebralmicrobleeds AT saundersannm apoetomm40geneticlociwhitematterhyperintensitiesandcerebralmicrobleeds AT rosesallend apoetomm40geneticlociwhitematterhyperintensitiesandcerebralmicrobleeds AT valdeshernandezmariadelc apoetomm40geneticlociwhitematterhyperintensitiesandcerebralmicrobleeds AT roylenataliea apoetomm40geneticlociwhitematterhyperintensitiesandcerebralmicrobleeds AT starrjohnm apoetomm40geneticlociwhitematterhyperintensitiesandcerebralmicrobleeds AT porteousdavidj apoetomm40geneticlociwhitematterhyperintensitiesandcerebralmicrobleeds AT dearyianj apoetomm40geneticlociwhitematterhyperintensitiesandcerebralmicrobleeds AT wardlawjoannam apoetomm40geneticlociwhitematterhyperintensitiesandcerebralmicrobleeds |